Biocapital: The Constitution of Postgenomic Life by Kaushik Sunder Rajan ( review). Article (PDF Available) in East Asian Science Technology and Society an. University of Sheffield. Biocapital: The Constitution of Postgenomic Life. By Kaushik Sunder Rajan. Pp. (Duke University Press, Durham and London, ). Biocapital: The Constitution of Postgenomic k Sunder Rajan. Pp. (Duke University Press, Durham and London, ) £, ISBN.
|Published (Last):||19 August 2009|
|PDF File Size:||11.76 Mb|
|ePub File Size:||7.44 Mb|
|Price:||Free* [*Free Regsitration Required]|
Contents Capitalisms and Biotechnologies.
Add a tag Cancel Be the first to add a tag for this edition. Title of the journal article or book chapter and contsitution of journal or title of book 3. Other editions – View all Biocapital: University of Queensland Library. Set up My libraries How do I set up “My libraries”? Australian National University Library. Surplus and Symptom Notes References Index Sunder Rajan integrates and explores in depth what many others only promise; i.
For book covers to accompany reviews, please contact the publicity department. These 2 locations in Victoria: You must obtain permission directly from the owner of the image. Biocapital gives lf passionate, thoroughly argued road map to dense and consequential worlds that I already inhabit, but have not known how to describe with the vividness and acumen required.
Language English View all posgtenomic Prev Next edition 2 of 2. Subjects Genomics — Economic aspects. In addition, Rajan’s research took place during an early stage of development of the genomics industry, before it had taken an estimated 15 years and billions of dollars to map all 3.
[email protected]: Biocapital : the constitution of post-genomic life
My library Help Advanced Book Search. Create a reading list or add to an existing list. The number of copies requested, the school and professor requesting For reprints and subsidiary rights, please also note: None of your libraries hold this item. Lists What are lists? The methodology followed in this dissertation is multi-sited ethnography. Nevertheless, his attempts to merge a multiplicity of Marxist and Foucauldian theories can be commendable.
Global and Local Political Ecologies of Biocapital. Sunder Rajan, Kaushik, Thus for the postgenomoc audience it presents an engaging study of the biosciences both in relation to the presentation and valuation of ethics and the interdependence of science and markets. Home All editions This editionEnglish, Book edition: Please check the credit line adjacent to the illustration, as well as the front and back matter of the book for a list of credits.
In a biotechnological utopia, with the DNA of the entire humanity mapped and sequenced, scientists and pharmaceutical companies can finally work together to provide highly customized diagnoses and cures for diseases and genetic defects.
Pharmocracy Asian Biotech Lively Capital.
Biocapital : the constitution of post-genomic life
Public Private login e. University of Western Australia. From witnessing an openly heated exchange between a corporate chief and a bioethicist in a conference in the United States to negotiating for access to interview subjects biocapotal Hyderabad in the face of deliberately bureaucratic hurdles, Kaushik Sunder Rajan attempts to come to grips with the complexities of the brave new world of genomics.
The University of Queensland. Notify us about copyright concerns. Biocapital is a major theoretical contribution to science studies and political economy.
This single location in Australian Capital Territory: While corporations, universities, and governments rushed bioccapital this sector in recent decades, the genomics industry has been creating new dynamics as well as hegemonies as it becomes increasingly plugged into the global political economy.
In contrast to the industrial economy of material products, the world of the genome industry becomes one that is determined by the intangibles of knowledge, information, and promises. Contact Contact Us Help.
Hence biocapital, which asks questions of the implications for life sciences when performed in corporations, and for capitalism, when biotechnology becomes a key source of market value. In lieu of an abstract, here is a brief excerpt of the content: